Drug Shortage Report for HALOPERIDOL INJECTION

Last updated on 2022-08-26 History
Report ID 163328
Drug Identification Number 02366010
Brand name HALOPERIDOL INJECTION
Common or Proper name Haloperidol Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-07-11
Actual start date 2022-07-07
Estimated end date 2022-08-25
Actual end date 2022-08-25
Shortage status Resolved
Updated date 2022-08-26
Company comments Product is now available
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-06-23 English Compare
v2 2022-06-23 French Compare
v3 2022-07-08 English Compare
v4 2022-07-08 French Compare
v5 2022-07-12 English Compare
v6 2022-07-20 English Compare
v7 2022-07-20 French Compare
v8 2022-08-01 English Compare
v9 2022-08-01 French Compare
v10 2022-08-08 English Compare
v11 2022-08-08 French Compare
v12 2022-08-09 English Compare
v13 2022-08-09 French Compare
v14 2022-08-09 English Compare
v15 2022-08-09 French Compare
v16 2022-08-19 English Compare
v17 2022-08-19 French Compare
v18 2022-08-25 English Compare
v19 2022-08-25 French Compare
v20 2022-08-25 English Compare

Showing 1 to 20 of 22